Governors Lane’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-204,229
Closed -$2.16M 231
2026
Q1
$2.16M Hold
204,229
0.14% 105
2025
Q4
$2.14M Buy
204,229
+1,066
+0.5% +$11.1K 0.13% 113
2025
Q3
$2.1M Hold
203,163
0.16% 92
2025
Q2
$2.09M Buy
+203,163
New +$2.06M 0.19% 89

Other funds holding TDAC

Governors Lane's TDAC Position: Q2 2026 in Review

Governors Lane sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 204,229 shares — an estimated $2.16M sold.

Governors Lane first reported a position in TDAC in Q2 2025 and held it in 4 quarters. The position peaked at $2.16M in Q1 2026. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Governors Lane reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Governors Lane sold 204,229 Translational Development Acquisition Corp shares in Q2 2026, an estimated $2.16M.
  • Governors Lane first reported a position in Translational Development Acquisition Corp in Q2 2025 and held it in 4 quarters.
  • Governors Lane's Translational Development Acquisition Corp position peaked at $2.16M in Q1 2026.
  • 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Governors Lane's 13F filing for Q2 2026, filed 14 Aug 2026.